tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Hazlett, 64 are a BUY (88.89%), 7 are a HOLD (9.72%), 1 are a SELL (1.39%).
Analyst Robert Hazlett, carries an average stock price target met ratio of 35% that have a potential upside of 48.46% achieved within 179 days. Previously, Robert Hazlett worked at BTIG.
Robert Hazlett’s has documented 124 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CMPS, Compass Pathways Plc at 24-Jun-2025.
Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 24-Feb-2025
$132
$0.13 (0.10%)
$100
10 months 17 days ago
(24-Feb-2025)
10/11 (90.91%)
$3.43 (2.67%)
292
Hold
Since 13-Jan-2025
$100
10 months 20 days ago
(21-Feb-2025)
21/22 (95.45%)
$-27.19 (-21.38%)
170
Hold
Since 25-Jun-2024
$132
$0.13 (0.10%)
$87
11 months 5 days ago
(05-Feb-2025)
8/9 (88.89%)
$4.97 (3.91%)
221
Hold
Since 31-Jan-2025
$132
$0.13 (0.10%)
$113
11 months 10 days ago
(31-Jan-2025)
12/13 (92.31%)
$4.92 (3.87%)
738
Buy
Since 26-Feb-2018
$132
$0.13 (0.10%)
$89
11 months 14 days ago
(27-Jan-2025)
10/11 (90.91%)
$4.79 (3.77%)
39
What Year was the first public recommendation made by Robert Hazlett?
